A Winning Combination for Clinical Diagnostics and Genetic Disease Drug Programs
Each year, the well-known analytics and growth strategy firm Frost & Sullivan recognizes disruptive and transformational companies with their Best Practices awards. They apply a rigorous selection process to identify candidates that are setting new standards, achieving visionary goals, and consistently pushing limits of what’s possible. Genomenon received the 2023 Frost & Sullivan Technology Innovation Leadership Award as the best-in-class company in the global pharma and clinical diagnostics genomics markets. This award underscores how Mastermind, our AI-powered genomic search engine, serves as a foundation for Genomenon’s success in both the clinical diagnostics and pharma markets. It also shines a spotlight on our sustained dedication to helping clients develop therapeutics for personalized medicine through our holistic approach to genomics interpretation and our customer-responsive practices.